Background: Non-invasive prenatal testing (NIPT) as a novel screening method has been widely proposed to screen for common fetal chromosomal aneuploidies. The aim of the present study was to examine the possible effects of maternal age, maternal weight, fetal crown-rump length (CRL), serum pregnancy-associated plasma protein A (PAPP-A), free beta-human chorionic gonadotropin (free β-hCG), and fetal gender on cell-free fetal DNA (cffDNA) percentage fluctuations. Methods: In the present cross-sectional study, 308 singleton pregnant women aged 20-47 years at 11+0 to 13+6 weeks of pregnancy referring to the DeNA Laboratory in Tehran, Iran, for NIPT test during a one-month period between July 2018 and August 2018 were selected randomly. The cffD...
334-340Adverse pregnancy outcomes such as preeclampsia are the leading cause of maternal morbidity a...
An important factor in quality control of non-invasive prenatal screening (NIPS) or testing (NIPT) i...
Objectives: To assess the association between low fetal fraction (FF) in prenatal cell-free DNA (cfD...
Recently published international guidelines recommend the clinical use of noninvasive prenatal test ...
Biological factors are known to influence the fetal fraction (FF) of cell-free DNA and may also infl...
185-191This gender-independent detection of cell-free fetal DNA in maternal plasma using RASSF1A/β-a...
Objective: The aim of the study was to evaluate the significance of the maternal blood level of preg...
OBJECTIVE: To assess the relationship between the first-trimester screening markers [pregnancy-assoc...
The aim of this study was to determine whether the increased serum cell-free fetal DNA (cffDNA) leve...
The aim of this study was to determine whether the increased serum cell-free fetal DNA (cffDNA) leve...
Objectives: To assess the association between low fetal fraction (FF) in prenatal cell-free DNA (cfD...
Background: Patients with atypical values of HCG and/or PAPP-A are at higher risk of chromosomal abn...
Noninvasive prenatal testing (NIPT) utilizing cell-free fetal DNA (cffDNA) in the maternal blood is ...
Objective: To compare available analysis methods for determining fetal fraction on single read next ...
OBJECTIVE: Our objective was to examine whether plasma fetal DNA can be used as a screening variable...
334-340Adverse pregnancy outcomes such as preeclampsia are the leading cause of maternal morbidity a...
An important factor in quality control of non-invasive prenatal screening (NIPS) or testing (NIPT) i...
Objectives: To assess the association between low fetal fraction (FF) in prenatal cell-free DNA (cfD...
Recently published international guidelines recommend the clinical use of noninvasive prenatal test ...
Biological factors are known to influence the fetal fraction (FF) of cell-free DNA and may also infl...
185-191This gender-independent detection of cell-free fetal DNA in maternal plasma using RASSF1A/β-a...
Objective: The aim of the study was to evaluate the significance of the maternal blood level of preg...
OBJECTIVE: To assess the relationship between the first-trimester screening markers [pregnancy-assoc...
The aim of this study was to determine whether the increased serum cell-free fetal DNA (cffDNA) leve...
The aim of this study was to determine whether the increased serum cell-free fetal DNA (cffDNA) leve...
Objectives: To assess the association between low fetal fraction (FF) in prenatal cell-free DNA (cfD...
Background: Patients with atypical values of HCG and/or PAPP-A are at higher risk of chromosomal abn...
Noninvasive prenatal testing (NIPT) utilizing cell-free fetal DNA (cffDNA) in the maternal blood is ...
Objective: To compare available analysis methods for determining fetal fraction on single read next ...
OBJECTIVE: Our objective was to examine whether plasma fetal DNA can be used as a screening variable...
334-340Adverse pregnancy outcomes such as preeclampsia are the leading cause of maternal morbidity a...
An important factor in quality control of non-invasive prenatal screening (NIPS) or testing (NIPT) i...
Objectives: To assess the association between low fetal fraction (FF) in prenatal cell-free DNA (cfD...